Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study - Kaufman, B; Mackey, J R; Clemens, M R (J Clin Oncol, 2009)
et al.